Trending: Roche to Buy Carmot Therapeutics in Deal Worth Up to $3.1 Billion
04 Diciembre 2023 - 9:12AM
Noticias Dow Jones
9:42 ET -- Roche is one of the most mentioned companies in the
U.S. across all news items in the last 12 hours, according to
Factiva data. The Swiss pharmaceutical company announced a deal to
buy Carmot Therapeutics for $2.7 billion with up to $400 million in
additional payments based on drug-development milestones. Roche
said it would be gaining Carmot's research-and-development
portfolio, including drugs it's developing to treat obesity and
type-1 and type-2 diabetes. Dow Jones & Co. owns Factiva.
(susan.solan@wsj.com)
(END) Dow Jones Newswires
December 04, 2023 09:57 ET (14:57 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Roche (QX) (USOTC:RHHBY)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
Real-Time news about Roche Holdings Ltd AG (QX) (OTCMarkets): 0 recent articles
Más de Roche Holdings Ltd AG (QX) Artículos de Noticias